Mid-Year Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$922,753

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

S. 3, relating to fair prescription drug prices for Medicare beneficiaries HR. 4, Medicare Prescription Drug Price Negotiation Act of 2007 Issues relating to Medicaid rebate

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); State, Dept of (DOS); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS)

Bills named: S. 3 (110th), H.R. 4 (110th)

Health Issues HCR

Issues relating to Medicaid drug pricing fraud HR 477 and S 999, Stop Stroke Act Issues relating to prevention of diversion and abuse of controlled substances Issues relating to pharmaceutical compounding Issues relating to the Montreal Protocol S. 1082, FDA Revitalization Act HR 2900, The FDA Amendments Act of 2007 S. 623 and HR 1038, Access to Life Saving Medicines Act S. 1695, Biologics Price Completion and Innovation Act of 2007

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); Treasury, Dept of

Bills named: S. 623 (110th), S. 1695 (110th), H.R. 477 (110th), H.R. 2900 (110th), S. 1082 (110th), H.R. 1038 (110th)

Trade (domestic/foreign) TRD

S. 1610, Foreign Investment and National Security Act of 2007 HR 556, National Security Foreign Investment Reform and Strengthened Transparency Act of 2007 Issues relating to Tariff

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: Treasury, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); State, Dept of (DOS)

Bills named: H.R. 556 (110th), S. 1610 (110th)

Taxation/Internal Revenue Code TAX

Protocol Amending the Convention Between the United States and Germany for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income and Capital and to Certain Other Taxes (Treaty Doc. 109-20)

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Treasury, Dept of; State, Dept of (DOS)

Copyright/Patent/Trademark CPT

S. 1145 & HR 1908, Patent Reform Act of 2006 S. 316, The Preserve Access to Affordable Generics Act

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: Environmental Protection Agency (EPA); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Treasury, Dept of; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1908 (110th), S. 316 (110th), S. 1145 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.